Click here to close now.




















Welcome!

News Feed Item

BMG PHARMA S.r.l - Milan, Italy - Has Granted Exclusive Distribution Rights to Samyang Biopharmaceutical Corporation for GelX® in the Territory of South Korea

MILAN, February 17, 2014 /PRNewswire/ --

BMG Pharma S.r.l. today is pleased to announce that it has signed an exclusive distribution agreement with Samyang Biopharmaceutical Corporation granting them the rights to promote, sell and market its novel mucositis management product GelX® in the territory of South Korea.

BMG Pharma S.r.l will receive an undisclosed down payment from Samyang Biopharmaceutical Corporation who will exclusively market GelX® in South Korea.

GelX® will allow patients to receive the best care possible by using an innovative delivery technology to provide fast pain relief and eliminate swallowing issues and discomfort associated with mucositis related to chemotherapy, radiotherapy, and other pharmacologic therapies.

BMG 's team were the originators of some of the major Rx medical devices in cancer supportive care including Radiation Dermatitis and Xerostomia and we are sure we are providing the market with a new generation of innovative products for support of cancer patients and we are very pleased of the commitment from a major company like SAMYANG for GelX® said Marco Mastrodonato, President and CEO of BMG Pharma S.r.l.

We are very pleased to work with BMG Pharma S.r.l. to launch GelX® in the South Korean market, said Cheolho Kwak, President of Samyang Biopharmaceutical Corporation, because the delivery technology associated with GelX® is a significant breakthrough in ease of use and compliance associated with patients presenting with especially chemotherapy/radiotherapy-induced Oral Mucositis.

About GelX®

BMG Pharma S.r.l. granted the exclusive distribution rights to Samyang Biopharmaceutical Corporation for GelX® in two different formulations : GelX® oral gel 300 ml and GelX® Oral spray 100 ml.

Mucositis and stomatitis are an inflammation of the oral cavity, normally accompanied by erythematous lesions and sometimes by ulcerative lesions that are particularly painful, making chewing and swallowing difficult.

GelX® Oral Gel and GelX® oral Spray have a mechanical action indicated for the management and relief of pain by adhering to the mucosal surface of the mouth, soothing the lesions caused by chemotherapy and/or radiation therapy.  

GelX®, in both formulations, is designated to benefit patients by improving the convenience, efficacy and compliance over existing marketed products.

About  Samyang  Biopharmaceutical Corporation

Samyang Biopharmaceutical Corporation is Samyang group's fully owned subsidiary company engaged in research and
development of innovative technology platforms for drug
delivery and novel application of its expertise in biopolymers
for developing pharmaceuticals and biomedical devices. Samyang Biopharmaceutical Corporation is currently striving to become leading specialty pharmaceutical company in Korea with primary focus on the development and commercialization of oncology and related pharmaceutical products using in-house R&D activities and licensing deals.

For additional information, please visit us at http://www.samyangbiopharm.com.

About  BMG Pharma S.r.l.

BMG Pharma S.r.l. is a Specialty Pharmaceutical Company with head office in Milan, Italy, leveraging its proprietary technology to develop products that address unmet needs of patients. The Company is currently focused on cancer supportive care, dermatology gynecology, ENT and oral health.  BMG Pharma S.r.l. is dedicated to helping patients, pharmacists and physicians by providing valuable and innovative products to the market.  

For press releases and other company information, visit: http://www.bmgpharma.com

Contact: Loredanan Galli, +39(02)91321756,  [email protected]

SOURCE BMG Pharma S.r.l.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...
It’s been proven time and time again that in tech, diversity drives greater innovation, better team productivity and greater profits and market share. So what can we do in our DevOps teams to embrace diversity and help transform the culture of development and operations into a true “DevOps” team? In her session at DevOps Summit, Stefana Muller, Director, Product Management – Continuous Delivery at CA Technologies, answered that question citing examples, showing how to create opportunities for ...
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
Any Ops team trying to support a company in today’s cloud-connected world knows that a new way of thinking is required – one just as dramatic than the shift from Ops to DevOps. The diversity of modern operations requires teams to focus their impact on breadth vs. depth. In his session at DevOps Summit, Adam Serediuk, Director of Operations at xMatters, Inc., will discuss the strategic requirements of evolving from Ops to DevOps, and why modern Operations has begun leveraging the “NoOps” approa...
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
In their Live Hack” presentation at 17th Cloud Expo, Stephen Coty and Paul Fletcher, Chief Security Evangelists at Alert Logic, will provide the audience with a chance to see a live demonstration of the common tools cyber attackers use to attack cloud and traditional IT systems. This “Live Hack” uses open source attack tools that are free and available for download by anybody. Attendees will learn where to find and how to operate these tools for the purpose of testing their own IT infrastructu...
SYS-CON Events announced today that IceWarp will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. IceWarp, the leader of cloud and on-premise messaging, delivers secured email, chat, documents, conferencing and collaboration to today's mobile workforce, all in one unified interface
Whether you like it or not, DevOps is on track for a remarkable alliance with security. The SEC didn’t approve the merger. And your boss hasn’t heard anything about it. Yet, this unruly triumvirate will soon dominate and deliver DevSecOps faster, cheaper, better, and on an unprecedented scale. In his session at DevOps Summit, Frank Bunger, VP of Customer Success at ScriptRock, will discuss how this cathartic moment will propel the DevOps movement from such stuff as dreams are made on to a prac...
Too often with compelling new technologies market participants become overly enamored with that attractiveness of the technology and neglect underlying business drivers. This tendency, what some call the “newest shiny object syndrome,” is understandable given that virtually all of us are heavily engaged in technology. But it is also mistaken. Without concrete business cases driving its deployment, IoT, like many other technologies before it, will fade into obscurity.
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...
SYS-CON Events announced today that G2G3 will exhibit at SYS-CON's @DevOpsSummit Silicon Valley, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Based on a collective appreciation for user experience, design, and technology, G2G3 is uniquely qualified and motivated to redefine how organizations and people engage in an increasingly digital world.